146 related articles for article (PubMed ID: 29394800)
1. [A Case of Unresectable Locally Advanced Pancreatic Cancer Resulted in R0 Surgery after Chemotherapy].
Sasaki Y; Katayama H; Hosoda Y; Komoto I; Sugimoto T; Yanagihara K; Katsushima U; Kawai J; Kiyochi H; Nishiyama K; Okabe A; Oshima Y; Tsunekawa S; Ogura N; Taki Y
Gan To Kagaku Ryoho; 2017 Nov; 44(12):1859-1861. PubMed ID: 29394800
[TBL] [Abstract][Full Text] [Related]
2. [Conversion Surgery for Initially Unresectable Locally Advanced Pancreatic Cancer Following Gemcitabine plus Nab-Paclitaxel - A Case Report].
Nakamoto S; Nishiyama R; Kaneda T; Yokota M; Kawamata H; Tajima H; Kaizu T; Kumamoto Y; Yamauchi H; Okuwaki K; Iwai T; Imaizumi H; Suzuki E; Hara A; Ichinoe M; Kida M; Watanabe M
Gan To Kagaku Ryoho; 2017 Feb; 44(2):173-176. PubMed ID: 28223678
[TBL] [Abstract][Full Text] [Related]
3. [A Case of Boderline Resectable Pancreatic Cancer Curatively Resected after Chemotherapy with Gemcitabine and Nab-Paclitaxel].
Kuwayama N; Natsume T; Kainuma O; Maruyama T; Tanaka H; Miyazaki A; Sato Y; Note H; Yoshioka T; Matsumoto Y; Suzuki K; Kato M; Oshima S; Ishigaki A; Mizumoto H; Shimizu S
Gan To Kagaku Ryoho; 2019 Apr; 46(4):721-724. PubMed ID: 31164515
[TBL] [Abstract][Full Text] [Related]
4. GEM + nab-PTX Therapy for Pancreatic Body Cancer cStage IVb for Conversion Surgery: A Case Report.
Yoshii H; Izumi H; Abe R; Tajiri T; Mukai M; Nomura E; Makuuchi H
Tokai J Exp Clin Med; 2019 Dec; 44(4):85-89. PubMed ID: 31768996
[TBL] [Abstract][Full Text] [Related]
5. [A Case of Borderline Resectable Pancreatic Cancer Responding to Preoperative GEM plus Nab-PTX Combination Chemotherapy].
Fujimoto T; Ueno T; Sakamoto K; Matsukuma S; Matsui H; Shindo Y; Tokumitsu Y; Kanekiyo S; Iida M; Tokuhisa Y; Suzuki N; Takeda S; Yoshino S; Hazama S; Nagano H
Gan To Kagaku Ryoho; 2016 Nov; 43(12):1978-1981. PubMed ID: 28133195
[TBL] [Abstract][Full Text] [Related]
6. A successful case of locally advanced pancreatic cancer undergoing curative distal pancreatectomy with en bloc celiac axis resection after combination chemotherapy of nab-paclitaxel with gemcitabine.
Hiyoshi M; Nanashima A; Wada T; Tsuchimochi Y; Hamada T; Yano K; Imamura N; Fujii Y
Clin J Gastroenterol; 2017 Dec; 10(6):551-557. PubMed ID: 29086227
[TBL] [Abstract][Full Text] [Related]
7. Nab-paclitaxel plus gemcitabine in patients with locally advanced pancreatic cancer (LAPACT): a multicentre, open-label phase 2 study.
Philip PA; Lacy J; Portales F; Sobrero A; Pazo-Cid R; Manzano Mozo JL; Kim EJ; Dowden S; Zakari A; Borg C; Terrebonne E; Rivera F; Sastre J; Bathini V; López-Trabada D; Asselah J; Saif MW; Shiansong Li J; Ong TJ; Nydam T; Hammel P
Lancet Gastroenterol Hepatol; 2020 Mar; 5(3):285-294. PubMed ID: 31953079
[TBL] [Abstract][Full Text] [Related]
8. Phase I study of chemoradiotherapy using gemcitabine plus nab-paclitaxel for unresectable locally advanced pancreatic cancer.
Yamada S; Fujii T; Yokoyama Y; Kawashima H; Maeda O; Suzuki K; Okada T; Ono E; Yamaguchi J; Takano N; Takami H; Hayashi M; Niwa Y; Hirooka Y; Ito Y; Naganawa S; Ando Y; Nagino M; Goto H; Kodera Y
Cancer Chemother Pharmacol; 2018 May; 81(5):815-821. PubMed ID: 29502139
[TBL] [Abstract][Full Text] [Related]
9. Total pancreatoduodenectomy en bloc with superior mesenteric artery and vein resection after gemcitabine and nab-paclitaxel neoadjuvancy.
Vicente E; Quijano Y; Ielpo B; Duran H
Surg Oncol; 2017 Sep; 26(3):276-277. PubMed ID: 29804945
[TBL] [Abstract][Full Text] [Related]
10. [A Case of Successful Adjuvant Surgery for the Pancreas Head Cancer with Peritoneal Metastasis].
Kyakumoto Y; Takadate T; Mizuma M; Hata T; Iseki M; Ohtsuka H; Sakata N; Nakagawa K; Morikawa T; Hayashi H; Motoi F; Naitoh T; Kanno A; Shimosegawa T; Unno M
Gan To Kagaku Ryoho; 2017 Nov; 44(12):1880-1882. PubMed ID: 29394807
[TBL] [Abstract][Full Text] [Related]
11. Nab-paclitaxel plus gemcitabine versus nab-paclitaxel plus gemcitabine followed by FOLFIRINOX induction chemotherapy in locally advanced pancreatic cancer (NEOLAP-AIO-PAK-0113): a multicentre, randomised, phase 2 trial.
Kunzmann V; Siveke JT; Algül H; Goekkurt E; Siegler G; Martens U; Waldschmidt D; Pelzer U; Fuchs M; Kullmann F; Boeck S; Ettrich TJ; Held S; Keller R; Klein I; Germer CT; Stein H; Friess H; Bahra M; Jakobs R; Hartlapp I; Heinemann V;
Lancet Gastroenterol Hepatol; 2021 Feb; 6(2):128-138. PubMed ID: 33338442
[TBL] [Abstract][Full Text] [Related]
12. Superior therapeutic efficacy of nab-paclitaxel over cremophor-based paclitaxel in locally advanced and metastatic models of human pancreatic cancer.
Rajeshkumar NV; Yabuuchi S; Pai SG; Tong Z; Hou S; Bateman S; Pierce DW; Heise C; Von Hoff DD; Maitra A; Hidalgo M
Br J Cancer; 2016 Aug; 115(4):442-53. PubMed ID: 27441498
[TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant-modified FOLFIRINOX vs nab-paclitaxel plus gemcitabine for borderline resectable or locally advanced pancreatic cancer patients who achieved surgical resection.
Wolfe AR; Prabhakar D; Yildiz VO; Cloyd JM; Dillhoff M; Abushahin L; Alexandra Diaz D; Miller ED; Chen W; Frankel WL; Noonan A; Williams TM
Cancer Med; 2020 Jul; 9(13):4711-4723. PubMed ID: 32415696
[TBL] [Abstract][Full Text] [Related]
14. [R0 Resection of Locally Advanced Pancreatic Cancer after Combination Chemotherapy with Gemcitabine and S-1].
Kametaka H; Makino H; Fukada T; Seike K; Koyama T; Hasegawa A
Gan To Kagaku Ryoho; 2015 Nov; 42(12):1641-3. PubMed ID: 26805123
[TBL] [Abstract][Full Text] [Related]
15. Comparisons of different neoadjuvant chemotherapy regimens with or without stereotactic body radiation therapy for borderline resectable pancreatic cancer: study protocol of a prospective, randomized phase II trial (BRPCNCC-1).
Gao S; Zhu X; Shi X; Cao K; Bian Y; Jiang H; Wang K; Guo S; Zhang H; Jin G
Radiat Oncol; 2019 Mar; 14(1):52. PubMed ID: 30917842
[TBL] [Abstract][Full Text] [Related]
16. [A Case of Pathological Complete Response Following Neoadjuvant Chemotherapy with Gemcitabine plus Nab-Paclitaxel in Borderline Resectable Pancreatic Cancer].
Ohno N; Ishida M; Ohnishi K; Sawai K; Tabata S; Deguchi M; Kitajima T; Kaizaki Y
Gan To Kagaku Ryoho; 2017 Nov; 44(12):1735-1738. PubMed ID: 29394759
[TBL] [Abstract][Full Text] [Related]
17. [Adjuvant Surgery for Initially Unresectable Locally Advanced Pancreatic Cancer following Gemcitabine and S-1 Chemotherapy--A Case Report].
Tono T; Kawasaki Y; Hashimoto M; Ikeda Y; Senba H; Okubo Y; Katayama T; Ishii T; Shinozaki K; Hayashi H; Yasuda S; Ohtsuru M
Gan To Kagaku Ryoho; 2015 Nov; 42(12):2373-5. PubMed ID: 26805368
[TBL] [Abstract][Full Text] [Related]
18. A clinical trial to assess the feasibility and efficacy of nab-paclitaxel plus gemcitabine for elderly patients with unresectable advanced pancreatic cancer.
Hasegawa R; Okuwaki K; Kida M; Yamauchi H; Kawaguchi Y; Matsumoto T; Kaneko T; Miyata E; Uehara K; Iwai T; Watanabe M; Kurosu T; Imaizumi H; Ohno T; Koizumi W
Int J Clin Oncol; 2019 Dec; 24(12):1574-1581. PubMed ID: 31309381
[TBL] [Abstract][Full Text] [Related]
19. [Multidisciplinary Therapy with Gemcitabine and Nab-Paclitaxel for Unresectable Pancreatic Cancer].
Motoi F; Takadate T; Maeda S; Ariake K; Masuda K; Ishida M; Fukase K; Mizuma M; Ohtsuka H; Sakata N; Hayashi H; Nakagawa K; Morikawa T; Naitoh T; Unno M
Gan To Kagaku Ryoho; 2017 Nov; 44(12):1241-1244. PubMed ID: 29394594
[TBL] [Abstract][Full Text] [Related]
20. The AGITG GAP Study: A Phase II Study of Perioperative Gemcitabine and Nab-Paclitaxel for Resectable Pancreas Cancer.
Barbour AP; Samra JS; Haghighi KS; Donoghoe MW; Burge M; Harris MT; Chua YJ; Mitchell J; O'Rourke N; Chan H; Gebski VJ; Gananadha S; Croagh DG; Kench JG; Goldstein D;
Ann Surg Oncol; 2020 Jul; 27(7):2506-2515. PubMed ID: 31997125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]